Rani Therapeutics Holdings, Inc.

RANI · Nasdaq · SIC 2834: Pharmaceutical Preparations
96
SEC Filings

Business Summary

PART I Overview We are a clinical stage biotherapeutics company focusing on advancing technologies to enable the administration of biologics and drugs orally, to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. We are advancing a portfolio of oral therapeutics using our proprietary delivery technology and we are actively pursuing partnering the technology with third party biopharmaceutical companies for the oral delivery of their biologics...

Next Earnings

Q2 FY2026 — expected 2026-08-12

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionRANIdiscussed_in_filing Cybersecurity
topic_mentionRANIdiscussed_in_filing Cybersecurity
topic_mentionRANIdiscussed_in_filing Healthcare & Bio
topic_mentionRANIdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-262025-12-310001193125-26-126417EDGAR108K words
2025-03-312024-12-310000950170-25-047740EDGAR—
2024-03-202023-12-310000950170-24-034163EDGAR—
2023-03-222022-12-310000950170-23-009178EDGAR—
2022-03-312021-12-310000950170-22-005088EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001193125-25-269774EDGAR27K words
2025-08-072025-06-300000950170-25-105045EDGAR—
2025-05-132025-03-310000950170-25-070382EDGAR—
2024-11-142024-09-300000950170-24-126763EDGAR—
2024-08-062024-06-300000950170-24-091793EDGAR—
2024-05-062024-03-310000950170-24-053548EDGAR—
2023-11-082023-09-300000950170-23-061137EDGAR—
2023-08-112023-06-300000950170-23-041852EDGAR—
2023-05-102023-03-310000950170-23-020554EDGAR—
2022-11-102022-09-300000950170-22-024442EDGAR—
2022-08-102022-06-300000950170-22-016492EDGAR—
2022-05-112022-03-310000950170-22-009334EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-260001193125-26-126240EDGAR3K words
2026-01-020001193125-26-001098EDGAR—
2025-11-060001193125-25-269722EDGAR—
2025-10-270001193125-25-250614EDGAR—
2025-10-170001193125-25-241963EDGAR—
2025-08-070000950170-25-104998EDGAR—
2025-07-160001193125-25-159793EDGAR—
2025-06-260000950170-25-090384EDGAR—
2025-05-290000950170-25-078949EDGAR—
2025-05-200001193125-25-122872EDGAR—

96 total filings indexed. 69 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001856725
TickerRANI
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedCA

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 9c9026919b95075dc7319426b44006274a5c1c427423ee327a3fed2321b41b8a
parent: 075eb9bcda082b25683ae580dcc240491538e9d5b0bedbbebf42e8c10ea5139a
content hash: 878452d9492a5a8b951fa8bd24f488dd490d7e9c27d48f3bab2970155e6f3e66
signed: 2026-04-13T04:47:07.267Z
sources: 17 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf